These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 18158484)
1. Vasodilators in the management of acute heart failure. Elkayam U; Janmohamed M; Habib M; Hatamizadeh P Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA; Hernandez AF Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602 [TBL] [Abstract][Full Text] [Related]
3. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations. Heywood JT; Khan TA Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department. Kirk JD; Parissis JT; Filippatos G Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385 [TBL] [Abstract][Full Text] [Related]
5. Overview of current noninodilator therapies for acute heart failure syndromes. Stough WG; O'Connor CM; Gheorghiade M Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822 [TBL] [Abstract][Full Text] [Related]
6. The role of vasodilator therapy in the management of the patient with acute myocardial infarction. Wagner GC; Robinson PH Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986 [No Abstract] [Full Text] [Related]
7. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575 [TBL] [Abstract][Full Text] [Related]
8. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
9. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide. Noviasky JA Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696 [TBL] [Abstract][Full Text] [Related]
10. [Vasodilators: treatment of cardiac insufficiency]. Francoual M; Lellouche D; Castaigne A; Estampes B; Vernant P Rev Prat; 1977 Oct; 27(47):3169-79. PubMed ID: 414346 [No Abstract] [Full Text] [Related]
11. [The role of nitrates in therapy of heart failure]. Strasser RH Herz; 1996 Jun; 21 Suppl 1():35-7. PubMed ID: 8767923 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects and safety of nesiritide in neonates with heart failure. Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856 [TBL] [Abstract][Full Text] [Related]
13. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
14. Vasodilator therapy of cardiac failure: (first of two parts). Cohn JN; Franciosa JA N Engl J Med; 1977 Jul; 297(1):27-31. PubMed ID: 405585 [No Abstract] [Full Text] [Related]
15. Critical review and recommendations for nesiritide use in the emergency department. Collins SP; Hinckley WR; Storrow AB J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453 [TBL] [Abstract][Full Text] [Related]